Drug info - Anyone heard of 2MD?

[Bezzz]

According to swim he has someone trying to sell him something called 2-MD, swim is convinced that this drug is actually a 2C-? drug, as he is being told they are trippy pills.

He tells me that he has searched erowid, DF and googled 2md but has found nothing.

swim said he would rather get a confirmation of what 2md is (or if anyones has been sold another RC labeled as 2md) before he samples it.

Thanks

[enquirewithin]

This doesn't sound like a complete name?

[aerozeppelin123]

I did a google search - the only mention of 2MD as a drug I could find was this anti-osteoporosis drug lol

UW-Developed Bone Growth Drug Goes into Phase 2 Clinical Trial

Date Posted: July 1, 2007

University of Wisconsin School of Medicine and Public Health (SMPH) researchers have begun a phase 2 clinical trial to see if a drug developed by Madison-based Deltanoid can promote new bone growth in post-menopausal women with low bone density.

Osteoporosis specialist Neil Binkley, MD, an SMPH associate professor of medicine, is the principal investigator on the UW arm of the study that will test the effectiveness of DP001, a new class of drug derived directly from Vitamin D. The drug, also known as 2MD, is the first major development of Deltanoid, the Madison-based company formed by Hector Deluca, PhD, a UW-Madison professor of biochemistry.

“We’re very enthusiastic about the possibilities here,” says Deluca, who first discovered DP001’s bone-building properties in 1998. “While we’re hoping eventually to be able to use this for everyone’s benefit, post-menopausal women are seriously affected by this issue. They’re the ones who tend to suffer extremely rapid bone loss.”

Currently, treatment options center on commonly prescribed drugs like Actonel™, Boniva™, and Fosamax™ that focus on preventing further breakdown of bone in patients with low bone density.

“What we need are drugs that build bone back up rather than simply prevent degradation,” says Binkley.

DP001 could be just that. Because it’s directly derived from Vitamin D, DP001 addresses both of the problems that lead to falls and bone fractures in postmenopausal women—poor bone density and muscle weakness. Because DP001 secretes an enzyme that makes it self-regulating, Binkley and Deluca aren’t concerned about toxicity or growing more bone than a patient requires.

DP001 is being studied at a number of centers in the United States, including the SMPH.

Studies showed that the compound induces new bone formation in animal models of osteoporosis. Phase 1 clinical trials uniformly demonstrated that the compound is safe and well tolerated, resulting in changes in bone biomarkers consistent with the formation of new bone.

If the current trial proves successful, Deluca says DP001 could be available commercially in five to six years.

Women eligible to participate in the study must be post-menopausal with borderline bone density and/or osteopenia. To enroll or learn more, contact the UW Health Osteoporosis Clinical Research Center at 265-6410.

http://www.med.wisc.edu/news/item.php?id=2239

[Bezzz]

hopefully there aren't going to be loads of grannies tripping out when they get prescribed bone medication lol.

Yeah swim is pretty sure that it is a 2C as he has spoken to someone else that has already had it and said they had on pill that weighed 60 mg (so the active ingredient would probably be around 20-25mg) and he felt medium euphoria and excellent visuals for around 7 hours from 1 pill.

Will post a pic and trip report when swim gets back to me with them.